Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

MDS - 540

THE VEXUS- MDS INTERFACE: INTEGRATING MORPHOLOGICAL MARKERS AND CLONAL EVOLUTION TO PREDICT RESPONSE TO TARGETED MYELOID CELL THERAPIES

Teshika Yalla

Poster Presenter: Teshika Yalla

Thumbnail for Therapeutic Architecture Rather Than Population Differences Drives Frontline Outcomes in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Comparison-Specific Pooled Analysis of Rituximab-Era Cohorts

ABCL - 397

Therapeutic Architecture Rather Than Population Differences Drives Frontline Outcomes in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Comparison-Specific Pooled Analysis of Rituximab-Era Cohorts

Adarsh Vardhan Tangella

Poster Presenter: Adarsh Vardhan Tangella

Previous 1...124 125 126 127 128 129 130...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for THERAPEUTIC DRUG MONITORING OF ONCE DAILY INTRAVENOUS BUSULFAN IN PAEDIATRIC PATIENTS UNDERGOING STEM CELL TRANSPLANTATION IN RESOURCE LIMITED SETTING

CT - 617

THERAPEUTIC DRUG MONITORING OF ONCE DAILY INTRAVENOUS BUSULFAN IN PAEDIATRIC PATIENTS UNDERGOING STEM CELL TRANSPLANTATION IN RESOURCE LIMITED SETTING

Saima humayun Toor

Poster Presenter: Saima humayun Toor

Thumbnail for Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review

MCL - 1190

Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review

Sunanda Chagam Reddy

Poster Presenter: Sunanda Chagam Reddy

Thumbnail for Therapeutic Strategies After CAR-T Failure in B-Cell Malignancies: A Systematic Review and Network Meta-Analysis

IBCL - 1000

Therapeutic Strategies After CAR-T Failure in B-Cell Malignancies: A Systematic Review and Network Meta-Analysis

Shrunga Kandhi Raghavendra

Poster Presenter: Shrunga Kandhi Raghavendra

Thumbnail for Therapeutic Targeting of SETD8 Suppresses Multiple Myeloma Growth Through the IRF4/MYC Axis

MM - 1091

Therapeutic Targeting of SETD8 Suppresses Multiple Myeloma Growth Through the IRF4/MYC Axis

Rudra Prasad Dutta

Poster Presenter: Rudra Prasad Dutta

Thumbnail for Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

AML - 357

Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

Tareq Abuasab

Poster Presenter: Tareq Abuasab

Thumbnail for Therapy-Related Myeloid Neoplasms Following CAR-T Therapy: Emerging Patterns, Risk Factors, and Clinical Challenges

CT - 1297

Therapy-Related Myeloid Neoplasms Following CAR-T Therapy: Emerging Patterns, Risk Factors, and Clinical Challenges

Safwan Muhammad

Poster Presenter: Safwan Muhammad

Thumbnail for Three Decades of Rising Disparity: Global Burden, Temporal Trends, and Sociodemographic Inequities of Multiple Myeloma in Females, 1990-2023

MM - 1738

Three Decades of Rising Disparity: Global Burden, Temporal Trends, and Sociodemographic Inequities of Multiple Myeloma in Females, 1990-2023

Deep Sangani

Poster Presenter: Deep Sangani

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors